Open-label placebos and electromagnetic hypersensitivity. A randomized controlled trial.

Open-label placebos and electromagnetic hypersensitivity. A randomized controlled trial. - EHS-OLP

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00023285

Enrollment

100

Registered

2020-10-14

Start date

2020-12-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

electromagnetic hypersensitivity.

Interventions

Group 1: The interventin group receives an open-label placebo for three weeks (2 each day) Group 2: control group (no placebos)

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Individuals who describe themselves as electro hypersensitive

Exclusion criteria

Exclusion criteria: known psychiatric or neurologic diseases

Design outcomes

Primary

Measure	Time frame
Symptoms of electro hypersensitivity (self developed questionnaire)	—

Secondary

Measure	Time frame
Health-related quality of life (SF-12)	—

Countries

Germany

Contacts

Public ContactMichael Schaefer

Medial School Berlin

michael.schaefer@medicalschool-berlin.de0306117542

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026